Zanzalintinib

DB17525InvestigationalSmall molecule

Zanzalintinib: Overview.

Chemical structure of Zanzalintinib
Formula / weight
C29H25FN4O5 · 528.54 g/mol (avg)
Also known as
XL092

Resolves to

Compound
UNIIKC2JC2ZA04CAS2367004-54-2
Structure
InChIKeyJSPCKALGNNVYOO-UHFFFAOYSA-NSMILESCNC(=O)C1=CC2=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)C=CN=C2C=C1OC
Targets
P08581MET

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
49Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Zanzalintinib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In